Objective Sarcopenia, defined by reductions in muscle mass and strength, increases the risk of adverse outcomes in patients with rheumatoid arthritis (RA)—driven in part by chronic inflammation—and is ...

Objectives Treatment of rheumatoid arthritis (RA) relies on immunomodulatory drugs that can compromise immunity, inducing secondary immunodeficiency (SID). However, features of SID, such as ...

Introduction Osteoarthritis is the second most prevalent musculoskeletal disorder and mostly affects hip and knee joints. Movement behaviours have been associated with the incidence of osteoarthritis.